, Singapore
409 views
Photo from Pfizer

Pfizer unveils new $1b manufacturing facility in Tuas Biomedical Park

The facility spans 429,000 sq ft.

Pfizer has launched its $1b Active Pharmaceutical Ingredient (API) manufacturing facility in Tuas Biomedical Park.

The facility spans 429,000 sq ft and will produce small molecule APIs for Pfizer’s oncology, pain, and antibiotic medicines globally. The expansion will also create over 250 jobs.

Construction began in 2020 and was designed to accommodate future additions such as processing suites, dry-end suites, dispensaries, a warehouse, and ancillary equipment. 

Design priorities included integrating systems and technologies to increase energy efficiency and manage energy demand effectively. The facility also holds a Green Mark Gold certification.

Follow the link for more news on

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!